학술논문

Economic evaluations of diagnostic process and neuropsychological assessment of dementia: a systematic review
Document Type
Academic Journal
Source
Global Business & Economics Review. May 30, 2022, Vol. 26 Issue 4, 365
Subject
Dementia -- Diagnosis
Health care industry -- Analysis
Health care industry
Business, international
Language
English
ISSN
1097-4954
Abstract
Alzheimer disease will have a strong growth rate among the adult population. Today, for healthcare managers, it would be extremely important to consider: the prevalence of the disease, and the demands for healthcare services. Adequate models have not yet been developed for estimating the evaluations of diagnostic tests useful for the decision-making process of healthcare managers. A systematic literature review was performed following the PRISMA checklist. The search retrieved 1,831 references. The highest impact of neuropsychological assessment was in France and Sweden. The lowest was in Spain and Netherlands. As for the total indirect costs, values varied from 630 international dollars (IntD$) in the USA, to IntD$956.25 in France for mild ALD patients. As for the moderate ALD, the lower value was in the USA (IntD$825), the medium in the UK (IntD$972.86), and the higher in Spain (IntD$1,123.33). Future research to better manage healthcare resources is recommended. Byline: Fiorella Pia Salvatore, Michele Milone, Emanuela Resta, Cristina Di Dio, Giancarlo Logroscino